Figure 2 illustrates both NK cell–intrinsic and tumor cell–intrinsic BET-regulated pathways identified in studies 52 and 87, and shows how BET inhibitors restores NK cell function, disrupts immune evasion, and supports tumor clearance. The gene discussed is DNER; the disease is neoplasm.